ACTRN12624000692538招募中4 期
Safety, tolerability and pharmacokinetics of 2g subcutaneous ceftriaxone as an alternative to intravenous administration in adult inpatients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Must meet all of:
- •- Age 18 years and older.
- •- Inpatient at Fiona Stanley Hospital
- •- Capacity to provide informed consent.
- •- Prescribed ceftriaxone 2g as part of their infection management plan.
排除标准
- •Patients will not be eligible for participation if any of the following criteria are met:
- •- Patients deemed to be clinically unstable (defined as requiring High-level dependency care (HDU)/Intensive care (ICU) or having had a medical emergency team (MET) call within the preceding 24 hours)
- •- Patients with a history of cognitive impairment, intellectual disability or a mental illness that leads to the inability to provide informed consent
- •- Children < 18 years.
- •- History of anaphylaxis or serious adverse reaction to cephalosporins in past.
研究者
相似试验
尚未招募
Unknown
A study to investigate the pharmacokinetics of subcutaneous administration of cefazolin and meropenemSubcutaneous antibiotic administrationInfection - Other infectious diseasesACTRN12623000577617aurens Manning60
尚未招募
2 期
IVERSAL2: Pharmacokinetics safety and acceptability of DRV/r for children living with HIVHIV/AIDSPACTR202405769820746Fondazione Penta ETS50
暂停
1 期
A study in healthy Japanese men to test how different doses of BI 894416 are toleratedJPRN-jRCT2080225328ippon Boehringer Ingelheim Co., Ltd.24
招募中
1 期
A study in healthy Japanese men to test how well different dosesof BI 1569912 are toleratedMajor Dipressive DisorderJPRN-jRCT2071210037Furuichi Takumi44
尚未招募
1 期
A study in healthy Japanese men to test how well different doses of BI 764198 are toleratedAJPRN-jRCT2071200055Ogawa Shintaro44